Axis-Shield introduces assay for osteoporosis marker
This article was originally published in Clinica
Executive Summary
Axis-Shield has developed an assay for detecting a genetic marker linked to osteoporosis. The test is based on identification of the unfavourable 'ss' allele of the COLIA1 gene - elderly individuals with this form of the gene are more than 3.5 times as likely to suffer a fracture as those with the 'SS' form. The test is so far only available for research use while the company builds awareness in the clinical community and generates sufficient data for regulatory approval for clinical use.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.